Current Duke Appointments & Affiliations
Assistant Professor of Medicine
·
2024 - Present
Medicine, Hematology,
Medicine
Recent Scholarly Works
Impact of cytoreductive therapy in myeloproliferative neoplasm-associated splanchnic vein thrombosis.
Journal article Blood Adv · November 24, 2026 Patients with myeloproliferative neoplasms (MPN) are at risk of splanchnic vein thrombosis (SVT). Previous studies have failed to demonstrate a benefit of hydroxyurea therapy in preventing recurrent thrombosis after SVT, but they are limited by small sampl ... Full text Link to item CiteThe complexity of provoked venous thromboembolism: one treatment plan does not fit all.
Journal article Blood Adv · November 10, 2026 The decision of whether to continue patients diagnosed with venous thromboembolism (VTE) on anticoagulation after the initial treatment period is often nuanced. Many patients will have ≥1 transient risk factor associated with a time-limited increased risk ... Full text Link to item CiteQualitative comparison of perioperative anticoagulation management guidelines across US institutions.
Journal article Thromb Res · January 2026 BACKGROUND: The indications for anticoagulation and the number of patients on anticoagulation is rising. Accordingly, adverse drug events related to anticoagulation use are on the rise and represents an opportunity for improvement in patient safety. About ... Full text Link to item CiteEducation
Lake Erie College of Osteopathic Medicine ·
2017
D.O.